Literature DB >> 6356768

Lymphomatoid granulomatosis involving the central nervous system: complication of a renal transplant with terminal monoclonal B-cell proliferation.

J Michaud, D Banerjee, J C Kaufmann.   

Abstract

A 33-year-old man, an immunosuppressed renal allograft recipient, developed fever of unknown etiology, multiple pulmonary densities, space-occupying lesions in the liver, confusion, disorientation, and seizures with cerebral infarcts. At autopsy, changes classical of active lymphomatoid granulomatosis (LYG) were found in the brain but those studied in the lungs and liver were in the healing phase. In addition, one cerebral focus in the right temporo-occipital lobe showed a lymphomatous transformation. Immunofluorescence studies done on this focus showed monoclonal IgG-lambda cytoplasmic staining in the perivascular infiltrate. Immunoperoxidase studies confirmed the monoclonal nature of this focus but showed a polyclonal pattern in the other foci. This finding is discussed along with the relationship between LYG and lymphoma.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6356768     DOI: 10.1007/bf00697394

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  27 in total

1.  Lymphomatoid granulomatosis.

Authors:  A A Liebow; C R Carrington; P J Friedman
Journal:  Hum Pathol       Date:  1972-12       Impact factor: 3.466

Review 2.  Malignant lymphoproliferative diseases induced by Epstein-Barr Virus in immunodeficient patients, including X-linked, cytogenetic, and familial syndromes.

Authors:  D T Purtilo
Journal:  Cancer Genet Cytogenet       Date:  1981-11

3.  [Primary brain lymphomas. Anatomoclinical, ultrastructural and immunocytochemical study about 23 cases (author's transl)].

Authors:  J Hassoun; L Andrac; D Gambarelli; M Toga
Journal:  Ann Pathol       Date:  1981       Impact factor: 0.407

4.  Lymphomatoid granulomatosis and Epstein-Barr virus.

Authors:  R W Veltri; P C Raich; J E McClung; S H Shah; P M Sprinkle
Journal:  Cancer       Date:  1982-10-15       Impact factor: 6.860

5.  An immunohistological study of immunoglobulin content of primary central nervous system lymphomas.

Authors:  C R Taylor; R Russell; R J Lukes; R L Davis
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

6.  Lymphomatoid granulomatosis of the larynx in a renal transplant recipient.

Authors:  G W Gardiner
Journal:  J Otolaryngol       Date:  1979-12

7.  Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.

Authors:  D W Hanto; G Frizzera; D T Purtilo; K Sakamoto; J L Sullivan; A K Saemundsen; G Klein; R L Simmons; J S Najarian
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

8.  Polymorphic reticulosis, lymphomatoid granulomatosis. Two diseases or one?

Authors:  R A DeRemee; L H Weiland; T J McDonald
Journal:  Mayo Clin Proc       Date:  1978-10       Impact factor: 7.616

9.  Lymphomatoid granulomatosis. Report of a case and review of the literature.

Authors:  R C Bone; M Vernon; R E Sobonya; H Rendon
Journal:  Am J Med       Date:  1978-10       Impact factor: 4.965

10.  [Immunohistochemical study in 16 cases of primary lymphoma of the central nervous system (author's transl)].

Authors:  C Jardon-Jeghers; M Reznik
Journal:  J Neurol Sci       Date:  1982-02       Impact factor: 3.181

View more
  3 in total

1.  Chronic encephalomyelitis presenting as chronic progressive myelopathy.

Authors:  T Yamamoto; J F Llena; E S Kim; A Hirano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-11       Impact factor: 10.154

2.  Lymphomatoid granulomatosis treated successfully with rituximab in a renal transplant patient.

Authors:  Cindy Castrale; Wael El Haggan; Françoise Chapon; Oumedaly Reman; Thierry Lobbedez; Jean Philippe Ryckelynck; Bruno Hurault de Ligny
Journal:  J Transplant       Date:  2011-04-19

3.  Lymphomatoid granulomatosis in a renal transplant patient.

Authors:  François Cachat; Kathleen Meagher-Villemure; Jean-Pierre Guignard
Journal:  Pediatr Nephrol       Date:  2003-06-12       Impact factor: 3.651

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.